{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:23:34Z","timestamp":1772187814048,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,13]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare autoimmune disease that can affect multiple organ systems. The standard treatment mainly relies on glucocorticoids and immunosuppressive agents. In our study, we present an EGPA patient who had pulmonary tuberculous mycobacteria infection, such cases are rarely reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 71-year-old male patient was diagnosed with EGPA (systemic type) and pulmonary tuberculosis simultaneously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The Five-Factor score indicated that the patient required glucocorticoids combined with immunosuppressive agents for induction therapy, however, the use of immunosuppressive agents would significantly inhibit antituberculosis treatment. Nowadays, treating active autoimmune disease in patients with infections remains a clinical challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Considering the patient did not show life-threatening or severe organ involvement and reduced the effect of antituberculosis immunity, we used glucocorticoids alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Finally, the patient had no adverse events, the eosinophil counts were markedly decreased and symptoms of EGPA were relieved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The patient of EGPA combined with pulmonary tuberculosis successfully treated with glucocorticoids alone may provide significant support in selecting the appropriate treatments for similar cases in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000039721","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T13:23:19Z","timestamp":1726579399000},"page":"e39721","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A case of eosinophilic granulomatosis with polyangiitis combined with pulmonary tuberculosis: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Yuting","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Respiratory, Longgang Central Hospital of Shenzhen, Shenzhen, Peoples\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Longgang Central Hospital of Shenzhen, Shenzhen, Peoples\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0228-5456","authenticated-orcid":false,"given":"Yan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Longgang Central Hospital of Shenzhen, Shenzhen, Peoples\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"103219","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: a review.","volume":"22","author":"White","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"e34450","DOI":"10.1097\/MD.0000000000034450","article-title":"ANCA-negative eosinophilic granulomatosis with polyangiitis complicated by peripheral nerve damage: a case report.","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1159\/000526410","article-title":"Effectiveness of low-dose mepolizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): a real-life experience.","volume":"183","author":"\u00d6zdel \u00d6zt\u00fcrk","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.3390\/jcm9123890","article-title":"Role of cytokines in EGPA and the possibility of treatment with an anti-IL-5 antibody.","volume":"9","author":"Isozaki","year":"2020","journal-title":"J Clin Med"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(03)12518-4","article-title":"Churg-strauss syndrome.","volume":"361","author":"Noth","year":"2003","journal-title":"Lancet"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.22686","article-title":"Long-term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).","volume":"68","author":"Durel","year":"2016","journal-title":"Arthritis Care Res"},{"key":"R7-20260203","first-page":"177","article-title":"Successful treatment using corticosteroids in early phase of eosinophilic myocarditis with eosinophilic granulomatosis with polyangiitis.","volume":"14","author":"Hase","year":"2016","journal-title":"J Cardiol Cases"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities.","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"550004","DOI":"10.3389\/fmed.2020.550004","article-title":"Incidence of tuberculosis in systemic necrotizing vasculitides: a population-based study from an intermediate-burden country.","volume":"7","author":"Ahn","year":"2020","journal-title":"Front Med"},{"key":"R10-20260203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-023-00847-2","article-title":"ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis.","volume":"21","author":"Yang","year":"2023","journal-title":"Pediatr Rheumatol"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis.","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1159\/000514505","article-title":"Clinical features of patients with active eosinophilic granulomatosis with polyangiitis successfully treated with mepolizumab.","volume":"182","author":"Tsurikisawa","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"R13-20260203","first-page":"2065","article-title":"Comparative analysis of the efficacies of the GeneXpert and solid culture media techniques in the diagnosis of mycobacterium tuberculosis.","volume":"77","author":"Nadeem","year":"2022","journal-title":"Arch Razi Inst"},{"key":"R14-20260203","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.cmi.2019.03.021","article-title":"The rapid molecular test Xpert MTB\/RIF Ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection.","volume":"25","author":"Opota","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R15-20260203","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(23)00097-8","article-title":"The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis.","volume":"11","author":"Sossen","year":"2023","journal-title":"Lancet Respir Med"},{"key":"R16-20260203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-020-00167-y","article-title":"The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report.","volume":"4","author":"Kato","year":"2020","journal-title":"BMC Rheumatol"},{"key":"R17-20260203","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1097\/CM9.0000000000000539","article-title":"Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.","volume":"132","author":"Weng","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"R18-20260203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/rheumatology\/keg066","article-title":"Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.","volume":"42","author":"Flores-Su\u00e1rez","year":"2003","journal-title":"Rheumatology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:00:47Z","timestamp":1770138047000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":18,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039721","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}